(NASDAQ: STIM) Neuronetics's forecast annual revenue growth rate of 8.75% is forecast to beat the US Diagnostics & Research industry's average forecast revenue growth rate of 5.66%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 25.31%.
Neuronetics's revenue in 2023 is $65,206,000.On average, 2 Wall Street analysts forecast STIM's revenue for 2023 to be $2,011,250,112, with the lowest STIM revenue forecast at $1,968,421,348, and the highest STIM revenue forecast at $2,054,078,876.
In 2024, STIM is forecast to generate $2,384,229,085 in revenue, with the lowest revenue forecast at $2,384,229,085 and the highest revenue forecast at $2,384,229,085.